Marshall D. Sklar
- Molecular Biology
- Oncology top 10%
- Immunology top 10%
- Genetics top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Michael PotterWallace P. RoweEdward V. ProchownikPaul A. SingerW. S. G. WalkerBen D.‐M. ChenAllan TerebaIra Green
- Topics
- Virus-based gene therapy research (4 papers)Neuroblastoma Research and Treatments (4 papers)Cell death mechanisms and regulation (3 papers)
- Cited by
- OncologyImmunologyMolecular Biology
- Partner nations
- United States
In The Last Decade
Marshall D. Sklar
18 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 615
- Oncology 398
- Immunology 236
- Genetics 206
- Radiology, Nuclear Medicine and Imaging 167
Countries citing papers authored by Marshall D. Sklar
This map shows the geographic impact of Marshall D. Sklar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall D. Sklar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall D. Sklar more than expected).
Fields of papers citing papers by Marshall D. Sklar
This network shows the impact of papers produced by Marshall D. Sklar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall D. Sklar. The network helps show where Marshall D. Sklar may publish in the future.
Co-authorship network of co-authors of Marshall D. Sklar
This figure shows the co-authorship network connecting the top 25 collaborators of Marshall D. Sklar. A scholar is included among the top collaborators of Marshall D. Sklar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall D. Sklar. Marshall D. Sklar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 18 | |
| 3 | 4 | |
| 4 | 16 | |
| 5 | Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc. | 73 |
| 6 | 53 | |
| 7 | 309 | |
| 8 | Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. | 134 |
| 9 | 4 | |
| 10 | 79 | |
| 11 | 22 | |
| 12 | 4 | |
| 13 | 62 | |
| 14 | 53 | |
| 15 | 89 | |
| 16 | 33 | |
| 17 | 158 | |
| 18 | 23 |
About Marshall D. Sklar
Marshall D. Sklar is a scholar working on Neurology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Neuroblastoma Research and Treatments (4 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Oncology (398 citations), Immunology (236 citations) and Molecular Biology (615 citations). Marshall D. Sklar has collaborated with scholars based in United States. Frequent co-authors include Michael Potter, Wallace P. Rowe, Edward V. Prochownik, Paul A. Singer, W. S. G. Walker, Ben D.‐M. Chen, Allan Tereba, Ira Green, Ethan M. Shevach and Helen Coon. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.